123 related articles for article (PubMed ID: 8106055)
1. [The pharmacokinetic aspects of the clinical action of gidazepam].
Zherdev VP; Neznamov GG; Kolyvanov GB; Litvin AA; Otabekova SG
Eksp Klin Farmakol; 1993; 56(3):50-2. PubMed ID: 8106055
[TBL] [Abstract][Full Text] [Related]
2. [Gidazepam biotransformation and pharmacokinetics in different species of animals and man].
Kolyvanov GB; Zherdev VP; Chirkov AM; Otabekova SG; Litvin AA
Eksp Klin Farmakol; 1993; 56(3):48-50. PubMed ID: 8106054
[TBL] [Abstract][Full Text] [Related]
3. [An experimental study of the pharmacokinetic mechanisms for the development of gidazepam tolerance].
Garibova TL; Zherdev VP; Voronina TA; Kolyvanov GB; Otabekova SG
Eksp Klin Farmakol; 1993; 56(6):48-50. PubMed ID: 7906580
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of the clinical pharmacological action of a single dose of fenazepam with the EEG dynamics and pharmacokinetics].
Uvarova LG; Zherdev VP; Neznamov GG; Khrulenko-Varnitskiĭ IO; Sigunova EA
Farmakol Toksikol; 1986; 49(1):66-9. PubMed ID: 2868919
[TBL] [Abstract][Full Text] [Related]
5. [The effect of pharmaceutic aids on gidazepam biotransformation and bioavailability].
Otabekova SG; Kolyvanov GB; Zherdev VP; Litvin AA; Vyrovshchikova SM
Eksp Klin Farmakol; 1993; 56(6):50-2. PubMed ID: 7906581
[TBL] [Abstract][Full Text] [Related]
6. [The pharmacokinetic and biopharmaceutical evaluation of the new tranquilizer gidazepam].
Kolyvanov GB; Kruchenkov AA; Litvin AA; Zherdev VP; Otabekova SG
Eksp Klin Farmakol; 1993; 56(2):53-5. PubMed ID: 8102290
[TBL] [Abstract][Full Text] [Related]
7. [The pharmacokinetic characteristics of fenazepam in epileptics].
Maksutova EL; Sariev AK; Zherdev VP; Voronina TA; Zheleznova EV
Eksp Klin Farmakol; 1994; 57(2):16-8. PubMed ID: 7911365
[TBL] [Abstract][Full Text] [Related]
8. [Biokinetics of a new prodrug gidazepam and its metabolite].
Andronati SA; Zin'kovskiĭ VG; Totrova MIu; Golovenko NIa; Stankevich EA; Zhuk OV
Biull Eksp Biol Med; 1992 Jan; 113(1):45-7. PubMed ID: 1356504
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of loprazolam and its principal metabolite in young subjects and elderly hospital patients.
Ford S; Ankier SI; Corless D; Bevan CD; Pidgen AW; Robinson JD; Rangedara DC
Xenobiotica; 1987 Aug; 17(8):1001-9. PubMed ID: 2890241
[TBL] [Abstract][Full Text] [Related]
10. [The role of bemitil pharmacokinetics in realizing its therapeutic efficacy].
Boĭko SS; Zherdev VP; Neznamov GG
Farmakol Toksikol; 1991; 54(2):64-6. PubMed ID: 1679400
[TBL] [Abstract][Full Text] [Related]
11. [Relation between the dynamics of EEG indices after a single dose of the tranquilizer phenazepam and its efficacy during a course of treatment of patients with borderline neuropsychological disorders].
Uvarova LG; Titaeva MA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1701-9. PubMed ID: 4082841
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels and pharmacokinetics of single and multiple dose of tetrazepam in healthy volunteers.
Bun H; Philip F; Berger Y; Necciari J; Al-Mallah NR; Serradimign A; Cano JP
Arzneimittelforschung; 1987 Feb; 37(2):199-202. PubMed ID: 2883980
[TBL] [Abstract][Full Text] [Related]
13. [Correlations between the pharmacokinetic indices of the tranquilizer fenazepam in single and long-term administration to patients].
Zherdev VP; Aleksandrovskiĭ IuA; Neznamov GG; Rudenko GM; Antokhin EA
Farmakol Toksikol; 1987; 50(1):81-5. PubMed ID: 3556559
[TBL] [Abstract][Full Text] [Related]
14. [Clinicobiochemical parallels in borderline neuropsychic disorders].
Ushakov GK; Maslova AF; Kostiunina ZG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1663-6. PubMed ID: 6119860
[TBL] [Abstract][Full Text] [Related]
15. [Use of psychophysiologic indices for the prognosis of the clinical action of tranquilizers].
Aleksandrovskiĭ IuA; Ben'kovich BI; Marshak OV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):90-8. PubMed ID: 2907706
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of fenazepam and its metabolite 3-oxyfenazepam in animals of different species and in man].
Zherdev VP; Martynova LA; Caccia S; Garattini S; Ekonomov AL
Farmakol Toksikol; 1985; 48(1):31-5. PubMed ID: 2858403
[TBL] [Abstract][Full Text] [Related]
17. New approach in bioavailability study of two formulations of ethyl loflazepate.
Ba BB; Iliadis A; Durand A; Berger Y; Cano JP
Arzneimittelforschung; 1988 Oct; 38(10):1486-9. PubMed ID: 2904268
[TBL] [Abstract][Full Text] [Related]
18. [Circadian changes in the pharmacokinetics and effects of fenazepam in rats].
Zherdev VP; Larionov LP; Voronina TA; Janků J; Dvorianinov AA
Farmakol Toksikol; 1987; 50(3):75-9. PubMed ID: 2886363
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between the pharmacokinetic indices and the pharmacological effects of fenazepam in an experiment].
Zherdev VP; Voronina TA; Ekonomov AL; Martynova LA
Farmakol Toksikol; 1985; 48(6):67-70. PubMed ID: 2867930
[TBL] [Abstract][Full Text] [Related]
20. [Changes in the antioxidative activity and phospholipid composition of the erythrocytes in neurosis patients as affected by fenazepam].
Kaipova GD; Burlakova EB; Molochkina EM; Neznamov GG; Poiurovskiĭ MV
Biull Eksp Biol Med; 1988 Feb; 105(2):171-3. PubMed ID: 3349146
[No Abstract] [Full Text] [Related]
[Next] [New Search]
